Quercetin attenuates the effects of H2O2 on endoplasmic reticulum morphology and tyrosinase export from the endoplasmic reticulum in melanocytes

Molecular Medicine Reports

Volumn 11, Issue 6, 2015, Pages 4285-4290

  Guan, Cuiping ^a   Xu, Wen ^a   Hong, Weisong ^a   Zhou, Miaoni ^a   Lin, Fuquan ^a   Fu, Lifang ^a   Liu, Dongyin ^a   Xu, Aie ^a  

^a THE THIRD PEOPLE S HOSPITAL OF HANGZHOU   (China)

Author keywords

Endoplasmic reticulum; Hydrogen peroxide; Quercetin; Tyrosinase

Indexed keywords

ANDROGEN RECEPTOR; MICRORNA; MICRORNA 185; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; CALB2 PROTEIN, HUMAN; CALRETININ; HYDROGEN PEROXIDE; MONOPHENOL MONOOXYGENASE; PROTEIN BINDING; QUERCETIN; REACTIVE OXYGEN METABOLITE;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BINDING SITE; CELL GROWTH; CELL PROLIFERATION; CHROMATIN CONDENSATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LNCAP CELL LINE; LUCIFERASE ASSAY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROSTATE CARCINOMA; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION; TATA BOX; WILD TYPE; CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; ENDOPLASMIC RETICULUM; MELANOCYTE; METABOLISM; OXIDATIVE STRESS; PROTEIN TRANSPORT; ULTRASTRUCTURE;

CALBINDIN 2; CELL SURVIVAL; CELLS, CULTURED; ENDOPLASMIC RETICULUM; HUMANS; HYDROGEN PEROXIDE; MELANOCYTES; MONOPHENOL MONOOXYGENASE; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN TRANSPORT; QUERCETIN; REACTIVE OXYGEN SPECIES;

EID: 84924657792     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3242     Document Type: Article

References (32)

1. Taïeb A and Picardo M; VETF Members: The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 20: 27-35, 2007.
2. Le Poole IC, Das PK, van den Wijngaard RM, Bos JD and Westerhof W: Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 2: 145-153, 1993.
3. Schallreuter KU: Successful treatment of oxidative stress in vitiligo. Skin Pharmacol Appl Skin Physiol 12: 132-138, 1999.
4. Maresca V, Roccella M, Roccella F, et al: Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 109: 310-313, 1997.
5. Dell'Anna ML, Maresca V, Briganti S, et al: Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo. J Invest Dermatol 117: 908-913, 2001.
6. Schallreuter KU, Wood JM and Berger J: Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 97: 1081-1085, 1991.
7. Sravani PV, Babu NK, Gopal KV, et al: Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin. Indian J Dermatol Venereol Leprol 75: 268-271, 2009.
8. Salem MM, Shalbaf M, Gibbons NC, et al: Enhanced DNA binding capacity on up-regulated epidermal wild-type p53 in vitiligo by H2O2-mediated oxidation: a possible repair mechanism for DNA damage. FASEB J 23: 3790-3807, 2009.
9. Giovannelli L, Bellandi S, Pitozzi V, et al: Increased oxidative DNA damage in mononuclear leukocytes in vitiligo. Mutat Res 556: 101-106, 2004.
10. Westerhof W and d'Ischia M: Vitiligo puzzle: the pieces fall in place. Pigment Cell Res 20: 345-359, 2007.
11. Schallreuter KU, Elwary SM, Gibbons NC, Rokos H and Wood JM: Activation/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun 315: 502-508, 2004.
12. Jeong YM, Choi YG, Kim DS, et al: Cytoprotective effect of green tea extract and quercetin against hydrogen peroxide-induced oxidative stress. Arch Pharm Res 28: 1251-1256, 2005.
13. Nagata H, Takekoshi S, Takeyama R, Homma T and Yoshiyuki Osamura R. Quercetin enhances melanogenesis by increasing the activity and synthesis of tyrosinase in human melanoma cells and in normal human melanocytes. Pigment Cell Res 17: 66-73, 2004.
14. Dell'Anna ML, Mastrofrancesco A, Sala R, et al: Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Clin Exp Dermatol 32: 631-636, 2007.
15. Boissy RE, Liu YY, Medrano EE and Nordlund JJ: Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. J Invest Dermatol 97: 395-404, 1991.
16. Guan C, Lin F, Zhou M, et al: The role of VIT1/FBXO11 in the regulation of apoptosis and tyrosinase export from endoplasmic reticulum in cultured melanocytes. Int J Mol Med 26: 57-65, 2010.
17. Jinbo L, Zhiyuan L, Zhijian Z and WenGe D: Olfactory ensheathing cell-conditioned medium protects astrocytes exposed to hydrogen peroxide stress. Cell Mol Neurobiol 33: 699-705, 2013.
18. Hong WS, Hu DN, Qian GP, McCormick SA and Xu AE: Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation. Br J Dermatol 165: 520-525, 2011.
19. Malhotra JD and Kaufman RJ: The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol 18: 716-731, 2007.
20. Ron D and Walter P: Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8: 519-529, 2007.
21. Hartley T, Siva M, Lai E, et al: Endoplasmic reticulum stress response in an INS-1 pancreatic beta-cell line with inducible expression of a folding-deficient proinsulin. BMC Cell Biol 11: 59, 2010.
22. Zuber C, Fan JY, Guhl B and Roth J: Misfolded proinsulin accumulates in expanded pre-Golgi intermediates and endoplasmic reticulum subdomains in pancreatic beta cells of Akita mice. FASEB J 18: 917-919, 2004.
23. Toyofuku K, Wada I, Valencia JC, Kushimoto T, Ferrans VJ and Hearing VJ: Oculocutaneous albinism types 1 and 3 are ER retention diseases: Mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins. Faseb J 15: 2149-2161, 2001.
24. Halaban R, Cheng E, Zhang Y, et al: Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. Proc Natl Acad Sci USA 94: 6210-6215, 1997.
25. Berson JF, Frank DW, Calvo PA, et al: A common temperature-sensitive allelic form of human tyrosinase is retained in the endoplasmic reticulum at the nonpermissive temperature. J Biol Chem 275: 12281-12289, 2000.
26. Chiang PW, Oiso N, Gautam R, et al: The Hermansky-Pudlak syndrome 1 (HPS1) and HPS4 proteins are components of two complexes, BLOC-3 and BLOC-4, involved in the biogenesis of lysosome-related organelles. J Biol Chem 278: 20332-20337, 2003.
27. Kushimoto T, Valencia JC, Costin GE, et al: The Seiji memorial lecture: the melanosome: an ideal model to study cellular differentiation. Pigment Cell Res 16: 237-244, 2003.
28. Saffari Y and Sadrzadeh SM: Green tea metabolite EGCG protects membranes against oxidative damage in vitro. Life Sci 74: 1513-1518, 2004.
29. Quevedo WC Jr, Holstein TJ, Dyckman J and McDonald CJ: The responses of the human epidermal melanocyte system to chronic erythemal doses of UVR in skin protected by topical applications of a combination of vitamins C and E. Pigment Cell Res 13: 190-192, 2000.
30. Smit N, Vicanova J, Cramers P, Vrolijk H and Pavel S: The combined effects of extracts containing carotenoids and vitamins E and C on growth and pigmentation of cultured human melanocytes. Skin Pharmacol Physiol 17: 238-245, 2004.
31. Bischoff SC: Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care 11: 733-740, 2008.
32. Murakami A, Ashida H and Terao J: Multitargeted cancer prevention by quercetin. Cancer Lett 269: 315-325, 2008.